Table 3.
Posaconazole peak (Cmax) and average (Cavg) concentrations may be of predictive value in patients with invasive aspergillosis treated with 400 mg twice daily [37]
| Cmax (µg ml−1) | Cavg (µg ml−1) | Response |
|---|---|---|
| 0.142 | 0.134 | 24% (4 of 17) |
| 0.467–0.852 | 0.411–0.719 | >53% (18 of 34) |
| 1.48 | 1.25 | 75% (12 of 16) |